Skip to Main Content

Paper Details

Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection.
Cell
285
2021
COVID-, COVID-19, SARS, SARS-CoV, SARS-CoV-, SARS-CoV-2, SARS-CoV-2 antibodies, SARS-CoV-2 spike, Severe acute respiratory syndrome coronavirus, coronavirus disease, hCoV, hCoVs, human, human coronaviruses, humans, nucleocapsid proteins, patients
Author NameAffiliation
Anurag VermaPerelman School of Medicine, University of Pennsylvania
Holly RamageUniversity of Pennsylvania
Nuala J Meyerand Critical Care Medicine and Center for Translational Lung Biology, University of Pennsylvania Perelman School of Medicine
Sara CherryUniversity of Pennsylvania
Daniel J RaderPerelman School of Medicine, University of Pennsylvania
  • 1 - 5

Datasets

Release 1.2